Medicare Enrolled

Dr. Amanda McBride, ARNP

Physician Assistant · Pace, FL
Low-engagement
3874 HIGHWAY 90 STE 101, Pace, FL 32571
8509954244
In practice since 2006 (19 years)
NPI: 1740208149 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McBride from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McBride? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McBride

Dr. Amanda McBride is a physician assistant in Pace, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. McBride received a total of $5,625 from 38 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McBride is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $5,625 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,625
Total received (2021-2024)
Avg $1,406/year across 4 years
Top 6% in FL for physician assistant
38
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,625 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,987
2023
$1,451
2022
$1,029
2021
$1,157

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$969
ABBVIE INC.
$903
Lilly USA, LLC
$616
PFIZER INC.
$448
Amgen Inc.
$299
AstraZeneca Pharmaceuticals LP
$242
Takeda Pharmaceuticals U.S.A., Inc.
$214
AbbVie Inc.
$198
Biohaven Pharmaceuticals, Inc.
$177
Boehringer Ingelheim Pharmaceuticals, Inc.
$162
Biohaven Pharmaceutical Holding Company Ltd.
$151
Abbott Laboratories
$135
Janssen Pharmaceuticals, Inc
$109
Corcept Therapeutics
$95
GlaxoSmithKline, LLC.
$92
Neos Therapeutics, LP
$86
SANOFI-AVENTIS U.S. LLC
$78
Dexcom, Inc.
$75
Exact Sciences Corporation
$67
Merck Sharp & Dohme Corporation
$64
UPSHER-SMITH LABORATORIES LLC
$51
Merck Sharp & Dohme LLC
$49
Novartis Pharmaceuticals Corporation
$45
Lundbeck LLC
$32
JAZZ PHARMACEUTICALS INC.
$28
Kowa Pharmaceuticals America, Inc.
$27
Eisai Inc.
$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Astellas Pharma US Inc
$20
Sumitomo Pharma America, Inc.
$19
Corium, LLC
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Xeris Pharmaceuticals, Inc.
$18
Tris Pharma Inc
$17
Amarin Pharma Inc.
$16
Medtronic, Inc.
$15
kaleo, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 44.2% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · AUVI-Q · Adzenys XR-ODT · Aimovig · Azstarys · BELSOMRA · BEXSERO · COMIRNATY · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · GVOKE HYPOPEN · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LIVALO · Livalo · MOUNJARO · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREMARIN · QULIPTA · Repatha · Rybelsus · STEGLATRO · SUNOSI · TOSYMRA · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VENASEAL · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for physician assistant in FL.

Looking for a physician assistant in Pace?
Compare physician assistants in the Pace area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician Assistants within 10 mi
255
Per 100K population
131.6
County median income
$88,968
Nearest hospital
HCA FLORIDA WEST HOSPITAL
9.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. McBride is a physician assistant, and high industry engagement (low-engagement, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. McBride receive payments from pharmaceutical companies?
Yes. Dr. McBride received a total of $5,625 from 38 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. McBride) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →